<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biomedcentral.com/feeds/latestarticles/journal?journal=bmcpediatr&amp;quantity=&amp;format=rss&amp;version=">
        <title>BMC Pediatrics - Latest Articles</title>
        <link>http://www.biomedcentral.com/bmcpediatr/</link>
        <description>The latest research articles published by BMC Pediatrics</description>
        <dc:date>2009-06-25T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2431/9/42" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2431/9/41" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2431/9/40" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2431/9/39" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2431/9/38" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2431/9/37" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2431/9/36" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2431/9/35" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2431/9/34" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2431/9/33" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.biomedcentral.com/1471-2431/9/42">
        <title>Analysis of circulating hem-endothelial marker RNA levels in preterm infants</title>
        <description>Background:
Circulating endothelial cells may serve as novel markers of angiogenesis. These include a subset of hem-endothelial progenitor cells that play a vital role in vascular growth and repair. The presence and clinical implications of circulating RNA levels as an expression for hematopoietic and endothelial-specific markers have not been previously evaluated in preterm infants. This study aims to determine circulating RNA levels of hem-endothelial marker genes in peripheral blood of preterm infants and begin to correlate these findings with prenatal complications.
Methods:
Peripheral blood samples from seventeen preterm neonates were analyzed at three consecutive post-delivery time points (day 3&#8211;5, 10&#8211;15 and 30). Using quantitative reverse transcription-polymerase chain reaction we studied the expression patterns of previously established hem-endothelial-specific progenitor-associated genes (AC133, Tie-2, Flk-1 (VEGFR2) and Scl/Tal1) in association with characteristics of prematurity and preterm morbidity.
Results:
Circulating Tie-2 and SCL/Tal1 RNA levels displayed an inverse correlation to gestational age (GA). We observed significantly elevated Tie-2 levels in preterm infants born to mothers with amnionitis, and in infants with sustained brain echogenicity on brain sonography. Other markers showed similar expression patterns yet we could not demonstrate statistically significant correlations.
Conclusion:
These preliminary findings suggest that circulating RNA levels especially Tie2 and SCL decline with maturation and might relate to some preterm complication. Further prospective follow up of larger cohorts are required to establish this association.</description>
        <link>http://www.biomedcentral.com/1471-2431/9/42</link>
                <dc:creator>Tzipora Strauss</dc:creator>
                <dc:creator>Sally Metsuyanim</dc:creator>
                <dc:creator>Itai Pessach</dc:creator>
                <dc:creator>Irit Shuchan-Eisen</dc:creator>
                <dc:creator>Jacob Kuint</dc:creator>
                <dc:creator>Benjamin Dekel</dc:creator>
                <dc:source>BMC Pediatrics 2009, 9:42</dc:source>
        <dc:date>2009-06-25T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2431-9-42</dc:identifier>
        <prism:publicationName>BMC Pediatrics</prism:publicationName>
        <prism:issn>1471-2431</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>42</prism:startingPage>
        <prism:publicationDate>2009-06-25T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2431/9/41">
        <title>Trends in broad-spectrum antibiotic prescribing for children with acute otitis media in the United States, 1998-2004</title>
        <description>Background:
Overuse of broad-spectrum antibiotics is associated with antibiotic resistance. Acute otitis media (AOM) is responsible for a large proportion of antibiotics prescribed for US children. Rates of broad-spectrum antibiotic prescribing for AOM are unknown.
Methods:
Analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey, 1998 to 2004 (N = 6,878).  Setting is office-based physicians, hospital outpatient departments, and emergency departments. Patients are children aged 12 years and younger prescribed antibiotics for acute otitis media. Main outcome measure is percentage of broad-spectrum antibiotics, defined as amoxicillin/clavulanate, macrolides, cephalosporins and quinolones.
Results:
Broad-spectrum prescribing for acute otitis media increased from 34% of visits in 1998 to 45% of visits in 2004 (P &lt; .001 for trend). The trend was primarily attributable to an increase in prescribing of amoxicillin/clavulanate (8% to 15%; P &lt; .001 for trend) and macrolides (9% to 15%; P &lt; .001 for trend). Prescribing remained stable for amoxicillin and cephalosporins while decreasing for narrow-spectrum agents (12% to 3%; P &lt; .001 for trend) over the study period. Independent predictors of broad-spectrum antibiotic prescribing were ear pain, non-white race, public and other insurance (compared to private), hospital outpatient department setting, emergency department setting, and West region (compared to South and Midwest regions), each of which was associated with lower rates of broad-spectrum prescribing. Age and fever were not associated with prescribing choice.
Conclusions:
Prescribing of broad-spectrum antibiotics for acute otitis media has steadily increased from 1998 to 2004. Associations with non-clinical factors suggest potential for improvement in prescribing practice.</description>
        <link>http://www.biomedcentral.com/1471-2431/9/41</link>
                <dc:creator>Andrew Coco</dc:creator>
                <dc:creator>Michael Horst</dc:creator>
                <dc:creator>Angela Gambler</dc:creator>
                <dc:source>BMC Pediatrics 2009, 9:41</dc:source>
        <dc:date>2009-06-24T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2431-9-41</dc:identifier>
        <prism:publicationName>BMC Pediatrics</prism:publicationName>
        <prism:issn>1471-2431</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>41</prism:startingPage>
        <prism:publicationDate>2009-06-24T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2431/9/40">
        <title>Causes and differentials of childhood mortality in Iraq </title>
        <description>Background:
Limited information is available in Iraq regarding the causes of under-five mortality. The vital registration system is deficient in its coverage, particularly from rural areas where access to health services is limited and most deaths occur at home, i.e. outside the health system, and hence the cause of death goes unreported. Knowledge of patterns and trends in causes of under-five mortality is essential for decision-makers in assessing programmatic needs, prioritizing interventions, and monitoring progress. The aim of this study was to identify causes of under-five children deaths using a simplified verbal autopsy questionnaire.The objective was to define the leading symptoms and cause of death among Iraqi children from all regions of Iraq during 1994-1999.
Methods:
To determine the cause structure of child deaths, a simplified verbal autopsy questionnaire was used in interviews conducted in the Iraqi Child &amp; Maternal Mortality Survey (ICMMS) 1999 national sample. All the mothers/caregivers of the deceased children were asked open-ended questions about the symptoms within the two weeks preceding death; they could mention more than one symptom.
Results:
The leading cause of death among under-five children was found to be childhood illnesses in 81.2%, followed by sudden death in 8.9% and accidents in 3.3%. Among under-five children dying of illnesses, cough and difficulty in breathing were the main symptoms preceding death in 34.0%, followed by diarrhea in 24.4%. Among neonates the leading cause was cough/and or difficulty in breathing in 42.3%, followed by sudden death in 11.9%, congenital abnormalities in 10.3% and prematurity in 10.2%. Diarrhea was the leading cause of death among infants in 49.8%, followed by cough and/or difficulty in breathing in 26.6%. Among children 12-59 months diarrhea was the leading cause of death in 43.4%, followed by accidents, injuries, and poisoning in 19.3%, then cough/difficulty in breathing in 14.8%.
Conclusion:
In Iraq Under- five child mortality is one of the highest in the Middle East region; deaths during the neonatal period accounted for more than half of under-five children deaths highlighting an urgent need to introduce health interventions to improve essential neonatal care. Priority needs to be given to the prevention, early and effective treatment of neonatal conditions, diarrheal diseases, acute respiratory infections, and accidents. This study points to the need for further standardized assessments of under-5 mortality in Iraq.</description>
        <link>http://www.biomedcentral.com/1471-2431/9/40</link>
                <dc:creator>Naira Awqati</dc:creator>
                <dc:creator>Mohammad Ali</dc:creator>
                <dc:creator>Nada Al-Ward</dc:creator>
                <dc:creator>Faiza Majeed</dc:creator>
                <dc:creator>Khawla Salman</dc:creator>
                <dc:creator>Mahdi Al- Alak</dc:creator>
                <dc:creator>Naeema Al-Gasseer</dc:creator>
                <dc:source>BMC Pediatrics 2009, 9:40</dc:source>
        <dc:date>2009-06-22T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2431-9-40</dc:identifier>
        <prism:publicationName>BMC Pediatrics</prism:publicationName>
        <prism:issn>1471-2431</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>40</prism:startingPage>
        <prism:publicationDate>2009-06-22T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2431/9/39">
        <title>Anthroposophic therapy for children with chronic disease: a two-year prospective cohort study in routine outpatient settings</title>
        <description>Background:
Many children with chronic disease use complementary therapies. Anthroposophic treatment for paediatric chronic disease is provided by physicians and differs from conventional treatment in the use of special therapies (art therapy, eurythmy movement exercises, rhythmical massage therapy) and special medications. We studied clinical outcomes in children with chronic diseases under anthroposophic treatment in routine outpatient settings.
Methods:
In conjunction with a health benefit program, consecutive outpatients starting anthroposophic treatment for any chronic disease participated in a prospective cohort study. Main outcome was disease severity (Disease and Symptom Scores, physicians&apos; and caregivers&apos; assessment on numerical rating scales 0-10). Disease Score was documented after 0, 6, and 12 months, Symptom Score after 0, 3, 6, 12, 18, and 24 months.
Results:
A total of 435 patients were included. Mean age was 8.2 years (standard deviation 3.3, range 1.0-16.9 years). Most common indications were mental disorders (46.2% of patients; primarily hyperkinetic, emotional, and developmental disorders), respiratory disorders (14.0%), and neurological disorders (5.7%). Median disease duration at baseline was 3.0 years (interquartile range 1.0-5.0 years). The anthroposophic treatment modalities used were medications (69.2% of patients), eurythmy therapy (54.7%), art therapy (11.3%), and rhythmical massage therapy (6.7%). Median number of eurythmy/art/massage therapy sessions was 12 (interquartile range 10-20), median therapy duration was 118 days (interquartile range 78-189 days).From baseline to six-month follow-up, Disease Score improved by average 3.00 points (95% confidence interval 2.76-3.24 points, p&lt;0.001) and Symptom Score improved by 2.41 points (95% confidence interval 2.16-2.66 points, p&lt;0.001). These improvements were maintained until the last follow-up. Symptom Score improved similarly in patients not using adjunctive non-anthroposophic therapies within the first six study months.
Conclusions:
Children under anthroposophic treatment had long-term improvement of chronic disease symptoms. Although the pre-post design of the present study does not allow for conclusions about comparative effectiveness, study findings suggest that anthroposophic therapies may play a beneficial role in the long-term care of children with chronic illness.</description>
        <link>http://www.biomedcentral.com/1471-2431/9/39</link>
                <dc:creator>Harald Hamre</dc:creator>
                <dc:creator>Claudia Witt</dc:creator>
                <dc:creator>Gunver Kienle</dc:creator>
                <dc:creator>Christoph Meinecke</dc:creator>
                <dc:creator>Anja Glockmann</dc:creator>
                <dc:creator>Stefan Willich</dc:creator>
                <dc:creator>Helmut Kiene</dc:creator>
                <dc:source>BMC Pediatrics 2009, 9:39</dc:source>
        <dc:date>2009-06-19T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2431-9-39</dc:identifier>
        <prism:publicationName>BMC Pediatrics</prism:publicationName>
        <prism:issn>1471-2431</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>39</prism:startingPage>
        <prism:publicationDate>2009-06-19T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2431/9/38">
        <title>Reporting and methodologic quality of cochrane neonatal review group systematic reviews

</title>
        <description>Background:
The Cochrane Neonatal Review Group (CNRG) has achieved a lot with limited resources in producing high quality systematic reviews to assist clinicians in evidence-based decision-making. A formal assessment of published CNRG systematic reviews has not been undertaken; we sought to provide a comprehensive assessment of the quality of systematic reviews (both methodologic and reporting quality) published in CNRG.
Methods:
We selected a random sample of published CNRG systematic reviews. Items of the QUOROM statement were utilized to assess quality of reporting, while items and total scores of the Oxman-Guyatt Overview Quality Assessment Questionnaire (OQAQ) were used to assess methodologic quality. Two reviewers independently extracted data and assessed quality. A Student t-test was used to compare quality scores pre- and post-publication of the QUOROM statement.
Results:
Sixty-one systematic reviews were assessed. Overall, the included reviews had good quality with minor flaws based on OQAQ total scores (mean, 4.5 [0.9]; 95% CI, 4.27-4.77). However, room for improvement was noted in some areas, such as the title, abstract reporting, a priori plan for heterogeneity assessment and how to handle heterogeneity in case it exists, and assessment of publication bias. In addition, reporting of agreement among reviewers, documentation of trials flow, and discussion of possible biases were addressed in the review process.  Reviews published post the QUOROM statement had a significantly higher quality scores.
Conclusion:
The systematic reviews published in the CNRG are generally of good quality with minor flaws. However, efforts should be made to improve the quality of reports. Readers must continue to assess the quality of published reports on an individual basis prior to implementing the recommendations.</description>
        <link>http://www.biomedcentral.com/1471-2431/9/38</link>
                <dc:creator>Khalid AlFaleh</dc:creator>
                <dc:creator>Mohammed Al-Omran</dc:creator>
                <dc:source>BMC Pediatrics 2009, 9:38</dc:source>
        <dc:date>2009-06-17T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2431-9-38</dc:identifier>
        <prism:publicationName>BMC Pediatrics</prism:publicationName>
        <prism:issn>1471-2431</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>38</prism:startingPage>
        <prism:publicationDate>2009-06-17T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2431/9/37">
        <title>Anemia and growth failure among HIV-infected children in India: a retrospective analysis</title>
        <description>Background:
Anemia and poor nutrition have been previously described as independent risk factors for death among HIV-infected children. We sought to describe nutritional status, anemia burden and HIV disease correlates among infected children in India.
Methods:
We analyzed retrospective data from 248 HIV-infected children aged 1&#8211;12 years attending three outpatient clinics in South India (2004&#8211;2006). Standard WHO definitions were used for anemia, HIV staging and growth parameters. Statistical analysis included chi square, t tests, univariate and multivariate logistic regression analyses.
Results:
The overall prevalence of anemia (defined as hemoglobin &lt; 11 gm/dL) was 66%, and 8% had severe anemia (Hb &lt; 7 gm/dL). The proportion of underweight and stunted children in the population was 55% and 46% respectively. Independent risk factors of anemia by multivariate analysis included the pre-school age group (age younger than 6 years) (OR: 2.87; 95% CI: 1.45, 5.70; p &lt; 0.01), rural residence (OR: 12.04; 95% CI: 5.64, 26.00; p &lt; 0.01), advanced HIV disease stage (OR: 6.95; 95% CI: 3.06, 15.79; p &lt; 0.01) and presence of stunting (Height-for-age Z Score &lt; -2) (OR: 3.24; 95% CI: 1.65, 6.35; p &lt; 0.01). Use of iron/multivitamin supplementation was protective against risk of anemia (OR: 0.44; 95% CI: 0.22, 0.90; p = 0.03). Pulmonary tuberculosis was an independent risk factor in multivariate analysis (OR: 3.36; 95% CI: 1.43, 7.89; p &lt; 0.01) when correlated variables such as HIV disease stage and severe immunodeficiency, and nutritional supplement use were not included. Use of antiretroviral therapy (ART) was associated with a reduced risk of anemia (OR: 0.29; 95% CI: 0.16, 0.53; p &lt; 0.01). No significant association was found between anemia and gender, cotrimoxazole, or ART type (zidovudine versus stavudine).
Conclusion:
The high prevalence and strong interrelationship of anemia and poor nutrition among HIV-infected children in India, particularly those living in rural areas underscores the need for incorporating targeted nutritional interventions during national scale up of care, support and treatment among HIV-infected children.</description>
        <link>http://www.biomedcentral.com/1471-2431/9/37</link>
                <dc:creator>Anita Shet</dc:creator>
                <dc:creator>Saurabh Mehta</dc:creator>
                <dc:creator>Nirmala Rajagopalan</dc:creator>
                <dc:creator>Chitra Dinakar</dc:creator>
                <dc:creator>Elango Ramesh</dc:creator>
                <dc:creator>N Samuel</dc:creator>
                <dc:creator>C Indumathi</dc:creator>
                <dc:creator>Wafaie Fawzi</dc:creator>
                <dc:creator>Anura Kurpad</dc:creator>
                <dc:source>BMC Pediatrics 2009, 9:37</dc:source>
        <dc:date>2009-06-16T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2431-9-37</dc:identifier>
        <prism:publicationName>BMC Pediatrics</prism:publicationName>
        <prism:issn>1471-2431</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>37</prism:startingPage>
        <prism:publicationDate>2009-06-16T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2431/9/36">
        <title>Microcytosis and possible early iron deficiency in paediatric inpatients: a retrospective audit</title>
        <description>Background:
Iron deficiency anaemia is a common paediatric problem worldwide, with significant neurodevelopmental morbidity if left untreated. A decrease in the mean corpuscular volume (MCV) can be used as a surrogate marker for detecting early iron deficiency prior to definitive investigation and treatment. An audit cycle was therefore undertaken to evaluate and improve the identification, follow-up and treatment of abnormally low MCV results amongst the paediatric inpatients in an English district general hospital.
Methods:
The audit cycle was performed retrospectively over two three-month periods (February to April 2006; September to November 2006), amongst patients aged between one month and 16 years that had full blood counts performed whilst admitted on the paediatric ward. Patients with at least one abnormally low MCV result were identified, and their notes reviewed. We looked for any underlying explanation for the result, adequate documentation of the result as abnormal, and instigation of follow-up or treatment. In-between the two audit periods, the results of the first audit period were presented to the medical staff and suggestions were made for improvements in documentation and follow-up of abnormal results. The z-test was used to test for equality of proportions between the two audit samples.
Results:
Out of 701 inpatients across both audit periods that had full blood counts, 61 (8.7%) had a low MCV result. Only 15% of patients in each audit period had an identifiable explanation for their low MCV values. Amongst the remaining 85% with either potentially explicable or inexplicable results, there was a significant increase in documentation of results as abnormal from 25% to 91% of cases between the first and second audit periods (p = 0.00 using z-test). However, there was no accompanying increase in the proportion of patients who received follow-up or treatment for their abnormal results.
Conclusion:
Abnormal red cell indices that may indicate iron deficiency are frequently missed amongst paediatric inpatients. Medical staff education and the use of appropriate protocols or pathways could further improve detection and treatment rates in this setting.</description>
        <link>http://www.biomedcentral.com/1471-2431/9/36</link>
                <dc:creator>Deepak Subramanian</dc:creator>
                <dc:creator>Sarah Kitson</dc:creator>
                <dc:creator>Amit Bhaniani</dc:creator>
                <dc:source>BMC Pediatrics 2009, 9:36</dc:source>
        <dc:date>2009-05-29T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2431-9-36</dc:identifier>
        <prism:publicationName>BMC Pediatrics</prism:publicationName>
        <prism:issn>1471-2431</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>36</prism:startingPage>
        <prism:publicationDate>2009-05-29T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2431/9/35">
        <title>Systematic Review of interventions for children with Fetal Alcohol Spectrum Disorders</title>
        <description>Background:
Children with Fetal Alcohol Spectrum Disorders (FASD) may have significant neurobehavioural problems persisting into adulthood. Early diagnosis may decrease the risk of adverse life outcomes. However, little is known about effective interventions for children with FASD. Our aim is to conduct a systematic review of the literature to identify and evaluate the evidence for pharmacological and non-pharmacological interventions for children with FASD.
Methods:
We did an electronic search of the Cochrane Library, MEDLINE, EMBASE, PsychINFO, CINAHL and ERIC for clinical studies (Randomized controlled trials (RCT), quasi RCT, controlled trials and pre- and post-intervention studies) which evaluated pharmacological, behavioural, speech therapy, occupational therapy, physiotherapy, psychosocial and educational interventions and early intervention programs. Participants were aged under 18 years with a diagnosis of a FASD. Selection of studies for inclusion and assessment of study quality was undertaken independently by two reviewers. Meta-analysis was not possible due to diversity in the interventions and outcome measures.
Results:
Twelve studies met the inclusion criteria. Methodological weaknesses were common, including small sample sizes; inadequate study design and short term follow up. Pharmacological interventions, evaluated in two studies (both RCT) showed some benefit from stimulant medications. Educational and learning strategies (three RCT) were evaluated in seven studies. There was some evidence to suggest that virtual reality training, cognitive control therapy, language and literacy therapy, mathematics intervention and rehearsal training for memory may be beneficial strategies. Three studies evaluating social communication and behavioural strategies (two RCT) suggested that social skills training may improve social skills and behaviour at home and Attention Process Training may improve attention.
Conclusion:
There is limited good quality evidence for specific interventions for managing FASD, however seven randomized controlled trials that address specific functional deficits of children with FASD are underway or recently completed.</description>
        <link>http://www.biomedcentral.com/1471-2431/9/35</link>
                <dc:creator>Elizabeth Peadon</dc:creator>
                <dc:creator>Biarta Rhys-Jones</dc:creator>
                <dc:creator>Carol Bower</dc:creator>
                <dc:creator>Elizabeth Elliott</dc:creator>
                <dc:source>BMC Pediatrics 2009, 9:35</dc:source>
        <dc:date>2009-05-25T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2431-9-35</dc:identifier>
        <prism:publicationName>BMC Pediatrics</prism:publicationName>
        <prism:issn>1471-2431</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>35</prism:startingPage>
        <prism:publicationDate>2009-05-25T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2431/9/34">
        <title>Television viewing in Thai infants and toddlers: impacts to language development and parental perceptions </title>
        <description>Background:
Effects of television to language development in infants and toddlers, especially in the Asian children, are inconclusive. This study aimed to (a) study time spent on television in Thai infants and toddlers (age &lt; 2 years), (b) investigate the association between time spent on television (as recommended by the American Academy of Paediatrics (AAP), &lt; 2 hours per day) and language development in Thai 2-year-old children, and (c) explore parental perceptions on television toward their child&apos;s development.
Methods:
Two hundred and sixty children and their parents were recruited into the study. Time spent on television and parental perceptions on television viewing toward their child&apos;s development were recorded during face-to-face and telephone interviews. Language development was assessed at the age of 2 years using the Clinical Linguistic Auditory Milestone Scale (CLAMS), and parents&apos; report. Association between delayed language development and time spent on television viewing, as well as other various parameters such as gender, maternal education and family income, were analysed using a multivariate logistic regression model.
Results:
Most Thai infants and toddlers watched television at the age of 6 months, 1 year and 2 years old (98.0, 95.3 and 96.7%, respectively). On average, 1-year-old children watched television 1.23 &#177; 1.42 hours per day. This increased to 1.69 &#177; 1.56 hours per day when they were 2 years old. However, watching television longer than 2 hours per day did not associate with delayed language development. On multivariate logistic regression analysis, gender (male) was the only significant factor associated with delayed language development (OR = 6.9, 95% CI = 1.5&#8211;31.3). Moreover, 75%, 71%, and 66% of Thai parents believed that television viewing yielded benefits to children&apos;s developments.
Conclusion:
Thai children commenced watching television at an early age and the amount of television viewing time increased by age. Most parents had positive perceptions to television viewing. The study found no association between time spent on television viewing (&#8805; 2 hours per day) and delayed language development at the age of 2 years.Gender (male) was the only variable associated with delayed language development.</description>
        <link>http://www.biomedcentral.com/1471-2431/9/34</link>
                <dc:creator>Nichara Ruangdaraganon</dc:creator>
                <dc:creator>Jariya Chuthapisith</dc:creator>
                <dc:creator>Ladda Mo-suwan</dc:creator>
                <dc:creator>Suntree Kriweradechachai</dc:creator>
                <dc:creator>Umaporn Udomsubpayakul</dc:creator>
                <dc:creator>Chanpen Choprapawon</dc:creator>
                <dc:source>BMC Pediatrics 2009, 9:34</dc:source>
        <dc:date>2009-05-22T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2431-9-34</dc:identifier>
        <prism:publicationName>BMC Pediatrics</prism:publicationName>
        <prism:issn>1471-2431</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>34</prism:startingPage>
        <prism:publicationDate>2009-05-22T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2431/9/33">
        <title>Elective high-frequency oscillatory ventilation in preterm infants with respiratory distress syndrome: an individual patient data meta-analysis.</title>
        <description>Background:
Despite the considerable amount of evidence from randomized controlled trials and meta-analyses, uncertainty remains regarding the efficacy and safety of high-frequency oscillatory ventilation as compared to conventional ventilation in the early treatment of respiratory distress syndrome in preterm infants. This results in a wide variation in the clinical use of high-frequency oscillatory ventilation for this indication throughout the world. The reasons are an unexplained heterogeneity between trial results and a number of unanswered, clinically important questions. Do infants with different risk profiles respond differently to high-frequency oscillatory ventilation? How does the ventilation strategy affect outcomes? Does the delay &#8211; either from birth or from the moment of intubation &#8211; to the start of high-frequency oscillation modify the effect of the intervention? Instead of doing new trials, those questions can be addressed by re-analyzing the individual patient data from the existing randomized controlled trials.Methods/DesignA systematic review with meta-analysis based on individual patient data. This involves the central collection, validation and re-analysis of the original individual data from each infant included in each randomized controlled trial addressing this question.The study objective is to estimate the effect of high-frequency oscillatory ventilation on the risk for the combined outcome of death or bronchopulmonary dysplasia or a severe adverse neurological event. In addition, it will explore whether the effect of high-frequency oscillatory ventilation differs by the infant&apos;s risk profile, defined by gestational age, intrauterine growth restriction, severity of lung disease at birth and whether or not corticosteroids were given to the mother prior to delivery. Finally, it will explore the importance of effect modifying factors such as the ventilator device, ventilation strategy and the delay to the start of high-frequency ventilation.DiscussionAn international collaborative group, the PreVILIG Collaboration (Prevention of Ventilator Induced Lung Injury Group), has been formed with the investigators of the original randomized trials to conduct this systematic review. In the field of neonatology, individual patient data meta-analysis has not been used previously. Final results are expected to be available by the end of 2009.</description>
        <link>http://www.biomedcentral.com/1471-2431/9/33</link>
                <dc:creator>Filip Cools</dc:creator>
                <dc:creator>Lisa Askie</dc:creator>
                <dc:creator>Martin Offringa</dc:creator>
                <dc:creator>PreVILIG Collaboration Prevention of Ventilator Induced Lung Injury Study Group</dc:creator>
                <dc:source>BMC Pediatrics 2009, 9:33</dc:source>
        <dc:date>2009-05-16T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2431-9-33</dc:identifier>
        <prism:publicationName>BMC Pediatrics</prism:publicationName>
        <prism:issn>1471-2431</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>33</prism:startingPage>
        <prism:publicationDate>2009-05-16T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
